Get started
222

KANGSTEM BIOTECH CO., LTD.

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

217730 chart


Full chart

Key stats


Market capitalization
‪126.68 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−150 KRW
Net income (FY)
‪−21.95 B‬ KRW
Revenue (FY)
‪12.70 B‬ KRW
Shares float
‪44.60 M‬
Beta (1Y)
0.50

Employees


Employees (FY)
113
Change (1Y)
0
Revenue / Employee (1Y)
‪86.34 K‬ KRW
Net income / Employee (1Y)
‪−149.18 K‬ KRW

About KANGSTEM BIOTECH CO., LTD.


Sector
Health Technology
Industry
Biotechnology
CEO
Jong-Chun Na
Website
kangstem.com
Headquarters
Seoul
Founded
2010
ISIN
KR7217730001
FIGI
BBG00BDZ1NT0
KANGSTEM BIOTECH Co., Ltd. engages in the development and manufacture of stem cell therapy. It operates through the Stem Cell, Cosmetics, and Biopharma business divisions. The Stem Cell division focuses on separating multi-functional stem cells from human umbilical cord. The Cosmetics division sells products based on stem cell culture fluid. The Biopharma division engages in the wholesale distribution of pharmaceuticals. Its products include muscle pain treatment and toothpaste type gum medicine. Its services include next generation and gene-loaded stem cell. The company was founded by Kyung-Sun Kang on October 29, 2010 and is headquartered in Seoul, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 217730 is 2,650 KRW — it has decreased by −1.30% in the past 24 hours. Watch KANGSTEM BIOTECH CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KANGSTEM BIOTECH CO., LTD. stocks are traded under the ticker 217730.
217730 stock has risen by 25.00% compared to the previous week, the month change is a 31.51% rise, over the last year KANGSTEM BIOTECH CO., LTD. has showed a 99.10% increase.
217730 reached its all-time high on Jan 2, 2019 with the price of 18,565 KRW, and its all-time low was 1,165 KRW and was reached on Nov 16, 2023. View more price dynamics on 217730 chart.
See other stocks reaching their highest and lowest prices.
217730 stock is 8.24% volatile and has beta coefficient of 0.50. Track KANGSTEM BIOTECH CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is KANGSTEM BIOTECH CO., LTD. there?
Today KANGSTEM BIOTECH CO., LTD. has the market capitalization of ‪126.68 B‬, it has increased by 5.85% over the last week.
Yes, you can track KANGSTEM BIOTECH CO., LTD. financials in yearly and quarterly reports right on TradingView.
217730 net income for the last quarter is ‪−4.03 B‬ KRW, while the quarter before that showed ‪4.71 B‬ KRW of net income which accounts for −185.64% change. Track more KANGSTEM BIOTECH CO., LTD. financial stats to get the full picture.
No, 217730 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 113.00 employees. See our rating of the largest employees — is KANGSTEM BIOTECH CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KANGSTEM BIOTECH CO., LTD. EBITDA is ‪−14.16 B‬ KRW, and current EBITDA margin is −152.63%. See more stats in KANGSTEM BIOTECH CO., LTD. financial statements.
Like other stocks, 217730 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KANGSTEM BIOTECH CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KANGSTEM BIOTECH CO., LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KANGSTEM BIOTECH CO., LTD. stock shows the buy signal. See more of KANGSTEM BIOTECH CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.